A61K 38/38
Albumins
A61K38/38 (Albumins) appears on 698 US grants and 1,229 published applications in this corpus.
Search patents in A61K- Granted patents
- 698
- Published applications
- 1,229
- Assignees
- 582
- Inventors
- 1,882
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 5 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 3 | 0 |
| 1992 | 10 | 0 |
| 1993 | 11 | 0 |
| 1994 | 10 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 14 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 9 | 4 |
| 2002 | 6 | 10 |
| 2003 | 7 | 31 |
| 2004 | 7 | 26 |
| 2005 | 8 | 39 |
| 2006 | 13 | 37 |
| 2007 | 13 | 26 |
| 2008 | 12 | 35 |
| 2009 | 11 | 34 |
| 2010 | 14 | 59 |
| 2011 | 13 | 32 |
| 2012 | 21 | 50 |
| 2013 | 26 | 50 |
| 2014 | 36 | 60 |
| 2015 | 31 | 72 |
| 2016 | 40 | 93 |
| 2017 | 40 | 56 |
| 2018 | 39 | 55 |
| 2019 | 46 | 75 |
| 2020 | 35 | 58 |
| 2021 | 49 | 69 |
| 2022 | 28 | 69 |
| 2023 | 33 | 61 |
| 2024 | 23 | 47 |
| 2025 | 22 | 42 |
| 2026 | 16 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition comprising albumin for use in the treatment of amyotrophic lateral sclerosis (ALS) by plasma exchange15 Sep 2026US 12,734,220 B2Grifols Worldwide Operations Limited
- Delivery of nucleic acids, proteins and small molecules in vitreous vesicular bodies18 Aug 2026US 12,708,647 B2Cornell University
- Methods of administering chimeric antigen receptor immunotherapy18 Aug 2026US 12,709,639 B2Kite Pharma, Inc.
- Blood plasma fractions as a treatment for aging-associated cognitive disorders4 Aug 2026US 12,697,373 B2Alkahest, Inc.
- Albumin-proaerolysin prodrugs28 Jul 2026US 12,691,158 B2The Johns Hopkins University
- Extracellular Vesicles and Compositions Thereof1 Oct 2026US 2026/0294977 A1Exo Biologics SA
- Particles and suspensions comprising hyaluronan degrading agents and methods of use thereof1 Oct 2026US 2026/0295021 A1Halozyme Hypercon, Inc.
- Modified rna with decreased immunostimulatory properties24 Sep 2026US 2026/0284227 A1CureVac AG
- Blood Plasma Fractions as a Treatment for Aging-Associated Cognitive Disorders17 Sep 2026US 2026/0273026 A1Alkahest, Inc.
- Compositions of Blood Plasma Fractions and Blood Plasma Subfractions and Their Use in Treatment of Disease10 Sep 2026US 2026/0263512 A1Alkahest, Inc.
Most cited
By later US patents
- Preparation of particles for inhalation553US 5,985,309 AMassachusetts Institute of Technology · 1999
- Particles incorporating surfactants for pulmonary drug delivery537US 5,855,913 AMassachusetts Instite of Technology · 1999
- Medical implants and fibrosis-inducing agents330US 7,166,570 B2Angiotech International AG · 2007
- Drug delivery compositions and methods311US 4,963,367 AMedaphore, Inc. · 1990
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014